{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "chebi:CHEBI:26523",
      "entity_text" : "ROS",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Cellular_component" : [ "go:GO:0005783" ],
      "Species" : [ "taxonomy:10116" ]
    }
  },
  "verbose_text" : "In this regard, most therapeutic CeO 2 NPs applications are proposed based on their ability to reduce ROS levels and consequently, the levels of most inflammatory mediators, such as inducible nitric oxide synthase, nuclear factor kappabeta, tumor necrosis factor-alpha, and interleukins.",
  "reading_complete" : "2020-08-04T11:55:39Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:53:50Z",
  "trigger" : "levels",
  "evidence" : [ "ROS levels" ],
  "pmc_id" : "5557789",
  "score" : 0
}